Aim-To evaluate the nature of accelerated fibrinolysis in hepatosplenic schistosomiasis. Methods-The biological activity of plasminogen (Plg), plasminogen activators (PA), oC2-antiplasmin (u2-AP) and plasminogen activator inhibitor-I (PAI-1) was determined by photometric analysis in 15 compensated and 35 decompensated patients with endemic Egyptian hepatosplenomegaly. Quantitative measurement of plasma concentrations of tissue t-PA, t-PA-PAI-i complex, a2-antiplasminplasmin complex (CC2-APP), fibrinogen degradation products (FbDP), D-dimers (D-D), thrombin-antithrombin complex (TAT) and prothrombin fragment (F 1+2) complexes, using double antibody sandwich enzyme linked immunosorbent assays and grading of the degree of hepatic insufficiency according to the Child-Pugh classification, were also carried out. Results-The progressive deterioration of liver function in schistosomal patients, which matched the severity of the disease, led to simultaneous defects in profibrinolytic (decreased Plg and increased PA and t-PA) and antifibrinolytic (decreased a2-AP and PAI-1) factors-the latter defects being the most prominent-resulting in significant generation of plasmin (increased APP complexes) and therefore enhanced fibrinolysis (increased FbDP and D-dimer). The raised concentrations of FbDP, D-D, TAT and F 1+2 established its secondary nature. Conclusion-These findings suggest that the amount of PAI-I available to bind and neutralise circulating t-PA may be a critical factor in the progress of hyperfibrinolysis observed in hepatosplenic schistosomiasis, and that the pronounced reduction in its plasma concentration may be regarded as a potential warning indicator of haemostatic imbalance in decompensated schistosomal patients at high risk of variceal bleeding. (7 Clin Pathol 1996;49:990-993) 
Hepatosplenic schistosomiasis is a chronic liver disease that constitutes a major health problem in endemic areas. Bleeding oesophageal varices' and accelerated fibrinolysis2 ' are common and serious complications of Schistosoma mansoni infection. Hyperfibrinolysis is an important risk factor4 in liver cirrhosis, because cirrhotic patients with bleeding have a higher frequency of accelerated fibrinolysis`and those with hyperfibrinolysis are at high risk of gastrointestinal bleeding.48 A multifactorial pathogenesis for accelerated fibrinolysis in liver cirrhosis has been presumed,9-" but there have been few similar studies in hepatosplenic schistosomiasis.
This study was designed to assess the impact of bilharzial hepatic fibrosis (BHF) on the balance between profibrinolytic and antifibrinolytic proteins-the balance between plasminogen and a2-antiplasmin (a2-AP) and that between tissue-type plasminogen activator (t-PA) and plasminogen activator inhibitor-1 (PAI-1)-and to determine whether, and to what extent, in addition to synthetic reduction, the consumption of fibrinolytic components contributes to haemorrhagic diathesis in schistosomal patients.
Methods
Fifty patients with biopsy confirmed endemic Egyptian hepatosplenic schistosomiasis were included in this study. Diagnosis of patients with severe liver failure or those with acute haematemesis was based on liver biopsy performed during previous hospital admission. Fifteen healthy volunteers were selected from the medical and paramedical staff and served as controls; their age ranged from 22 to 48 years (nine men and six women). None of the subjects under study gave a history of alcohol intake or had taken drugs with known effects on coagulation or fibrinolysis, specially 5-blockers and oral contraceptives; and each gave informed consent.
The cause of liver disease was Schistosoma mansoni infection either alone (1 1 subjects) or coexistent with viral hepatitis (B and/or C) in 39 patients. Assessment of BHF, including bilharzial portal fibrosis and associated parenchymal changes, and mixed hepatic lesions showing histopathological features of both BHF and chronic active hepatitis (CAH), was based on several morphological criteria, as described before.'2 Patients were studied when they first presented and were grouped into compensated (n = 15) or decompensated, either hepatocellular (n = 15) or vascular (n = 20), if ascites and/or acute haematemesis from ruptured oesophageal varices (defined as vomiting of fresh red blood and diagnosed by emergency endoscopy) superimposed. The degree of hepatic insufficiency was determined using Child-Pugh criteria. 1314 Except for patients with acute haematemesis, blood was collected by venepuncture between 0830 and 1000 hours from resting individuals who had fasted overnight. Blood samples from the former patients were withdrawn without any medication, blood transfusion, component therapy, endoscopic ligation or injection sclerotherapy. Blood (9 volumes) was mixed with buffered citrate, 0.1 mol/l, pH 4.5 (1 volume) (Behring Institute, Behringwerke AG, Marburg, Germany), centrifuged (1500 x g, at 4°C for 10 minutes), aliquoted, and stored at -70°C until assayed.
Fibrinogen was quantitated in plasma by a functional assay according to the method of Data are presented as median and range. Differences between groups were tested for significance using the Mann-Whitney U test. Regression analysis to determine significant correlations among different parameters was performed using the Spearman rank correlation coefficient. A 95% and 99% confidence interval was quoted.
Results
The clinical and histopathological characteristics of schistosomal patients are shown in table 1 . Different degrees of hepatic dysfunction according to the Child-Pugh classification were detected. While Child A grade was prevalent (100%) in compensated patients, 47% and 41% of patients with Child B grade were found among cases with haematemesis and ascites, respectively. Twenty patients were graded as Child C; 40% and 60% of them were found among the ascites and haematemesis groups, respectively. Histopathological examination of liver biopsy specimens revealed the presence of three morphological features: (a) pure BHF; (b) mixed BHF and CAH; and (c) mixed lesions merging into cirrhosis. Seventy eight per cent (39/50) of patients had mixed BHF and CAH, which may explain the high incidence of clinical and hepatic decompensation in schistosomal patients. Table 2 shows that the plasma concentrations of fibrinogen, plasminogen, (X2-AP and PAI-I were significantly decreased (p < 0.01) in diseased groups compared with controls. The decrease in these parameters matched the severity of the disease as patients with ascites and/or acute haematemesis had significantly lower (p < 0.01) concentrations than compensated patients. Conversely, PA, t-PA, t-PA-PAI-I and a2-APP complexes, FbDP, D-D, TAT and F 1+2 complexes were significantly increased (p < 0.01) in diseased groups than in controls, and these concentrations progressively increased as the disease progressed. The highest values were mostly encountered in patients during acute attacks of haematemesis. Decompensated patients with acute haematemesis had significant increases in TAT (p < 0.05) and F 1+2 (p < 0.01) concentrations along with significant reductions (p < 0.05) in PAI-1 concentrations than patients with ascites. Although a decrease in plasminogen and a2-AP concentrations, and an increase in free t-PA concentration were also detected in patients with haematemesis, the differences were not significant (p > 0.05).
A highly significant direct correlation was found between t-PA and t-PA-PAI-1 complex in ascites (r = 0.9692, p < 0.001) and haematemesis (r = 0.9216, p < 0.001) groups. Although no significant correlation (p > 0.05) was detected between PA activity and either t-PA or t-PA-PAI-1 complex concentrations in ascites (r = 0.3314 and r = 0.1245, respectively) and haematemesis (r = 0.3938 and r = 0.1970, respectively) groups, a highly significant correlation was found between its activity and free t-PA in patients with ascites (r = Furthermore, endotoxaemia inducing increased plasminogen activator production34 has been suggested as a further contributing factor in schistosomal patients.3'5 However, PAI-1 activity was significantly reduced.
Raised specific functional activity of PA was detected in schistosomal patients, but this activity did not correlate with either t-PA or t-PA-PAI-1 complex, but correlated strongly with free t-PA. Moreover, the ratios of t-PA antigen and PAI-1 activity were concomitantly increased with worsening liver damage. The fact that PAI-1 is partly synthesised by the liver36 and partly by endothelial cells,37 whereas t-PA is synthesised only by endothelial cells,38 may account for this change in t-PA/PAI-1 balance. These findings are consistent with data from other studiesl' which attributed the increased fibrinolytic activity in liver cirrhosis to increased plasminogen activators, causing consumption oftheir inhibitors and resulting in bleeding episodes. Patients with acute haematemesis mostly had a pronounced reduction in PAI-1 activity compared with those in the ascites group; the increase in free t-PA and PA activity in the former group, however, was not significant.
Significant decreases in plasminogen and X2-AP concentrations were detected in hepatosplenic schistosomal patients compared with controls. Impaired hepatic synthesis may account for this reduction in their concentrations as it is correlated with the degree of liver insufficiency and the presence of mixed infection. The decrease in their concentrations may also be attributable to high t-PA activity, resulting in their increased consumption. The fact that a2-AP concentration was lower than that of plasminogen in hepatosplenic patients, especially those with acute haematemesis, may potentiate the tilting of the balance towards hyperfibrinolysis and thence haemorrhage and imply a contributory role for aX2-AP in its pathogenesis. Similar findings8 have been reported in liver cirrhosis.
Our data show that the progressive deterioration of liver function in patients with hepatosplenic schistosomiasis increasingly impacts on the plasma concentrations of fibrinolytic components and, therefore, on the whole fibrinolytic system. In decompensated patients these changes may be the direct result of massive liver injury. Increased t-PA relative to PAI-I can result in extremely high t-PA activity; this in turn can stimulate the generation of plasmin, which is inadequately inhibited by the decreased C2-AP, and therefore may lead to enhanced fibrinolysis. In compensated patients inhibitory activity (x2-AP and PAI-1) seems to be present in sufficient quantities, possibly limiting the incidence of bleeding due to 
